Effects of age and gender on preladenant pharmacokinetics in healthy subjects

被引:0
|
作者
Cutler, D. L.
Tendolkar, A.
Hunter, J.
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S259 / S260
页数:2
相关论文
共 50 条
  • [1] The effects of age and gender on the pharmacokinetics and pharmacodynamics in healthy subjects of the plasminogen activator, lanoteplase
    Vachharajani, Nimish N.
    Raymond, Ralph H.
    Shyu, Wen-Chyi
    Stouffer, Bruce C.
    Boulton, David W.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 72 (05) : 775 - 786
  • [2] NO EFFECTS OF GENDER, AGE AND FOOD ON THE PHARMACOKINETICS OF CC-930 IN HEALTHY SUBJECTS
    Thomas, M. E., Jr.
    Wu, A.
    Liu, L.
    Kong, L.
    Choudhury, S.
    Yes, Y.
    Parmesan, M.
    Laski, O. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S26 - S26
  • [3] The effects of age and gender on the single-dose pharmacokinetics and safety of saxagliptin in healthy subjects
    Boulton, David W.
    Goyal, Anita
    Li, Li
    Korn-Hauser, David M.
    Frevert, Uli
    DIABETES, 2008, 57 : A164 - A164
  • [4] Effects of age and gender on febuxostat pharmacokinetics. Pharmacodynamics, and safety in healthy subjects.
    Khosravan, R
    Kukulka, M
    Wu, JT
    Joseph-Ridge, N
    Vernillet, L
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P50 - P50
  • [5] Effects of age and gender on the pharmacokinetics of bromfenac in healthy volunteers
    Boni, JP
    DeCleene, SA
    Cevallos, WH
    Hicks, DR
    KorthBradley, JM
    ANNALS OF PHARMACOTHERAPY, 1997, 31 (04) : 400 - 405
  • [6] Effect of age and gender on single-dose pharmacokinetics of entecavir in healthy subjects
    Yan, JH
    Bifano, M
    Xie, J
    Zhang, D
    Grasela, D
    LaCreta, F
    ANTIVIRAL THERAPY, 2004, 9 (06) : H23 - H23
  • [7] Gender and age effects on elbow joint stiffness in healthy subjects
    Lin, CCK
    Ju, MS
    Huang, HW
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2005, 86 (01): : 82 - 85
  • [8] The effects of age, gender, and season on serotonergic function in healthy subjects
    Golden, RN
    Gilmore, JH
    Ekstrom, RD
    Knight, B
    Ruegg, RG
    Miller, HL
    Carson, SW
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1996, 20 (08): : 1315 - 1323
  • [9] Absence of age and gender effects on the pharmacokinetics of a single 500-milligram oral dose of levofloxacin in healthy subjects
    Chien, SC
    Chow, AT
    Natarajan, J
    Williams, RR
    Wong, FA
    Rogge, MC
    Nayak, RK
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (07) : 1562 - 1565
  • [10] EFFECTS OF AGE, GENDER, AND RACE ON THE SAFETY AND PHARMACOKINETICS OF SINGLE AND MULTIPLE DOSES OF AZILSARTAN MEDOXOMIL IN HEALTHY SUBJECTS.
    Harrell, R., Jr.
    Karim, A.
    Zhang, W.
    Dudkowski, C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S78 - S78